ID   CA
AC   CVCL_E319
DR   IARC_TP53; 21040
DR   TKG; TKG 0692
DR   Wikidata; Q54808280
RX   PubMed=14751132;
RX   PubMed=35692560;
CC   Population: Japanese.
CC   Doubling time: 14.3 hours (PubMed=14751132).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): TKG=TKG 0692
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 11
ST   D5S818: 11,15
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 17
//
RX   PubMed=14751132; DOI=10.1016/j.ygyno.2003.09.014;
RA   Isaka, Keiichi
RA   Nishi, Hirotaka
RA   Osakabe, Yumi
RA   Miyata, Machiko
RA   Hokamura, Mitsuyasu
RA   Nakada, Toshihide
RA   Itokazu, Osamu
RA   Takayama, Masaomi
RT   "Establishment of a HPV and p53-mutation-negative human cell line (CA)
RT   derived from a squamous carcinoma of the uterine cervix.";
RL   Gynecol. Oncol. 92:15-21(2004).
//
RX   PubMed=35692560; DOI=10.1080/23723556.2022.2078628; PMCID=PMC9176225;
RA   de Lourdes Zuniga-Martinez, Ma
RA   Lopez-Mendoza, Carlos Miguel
RA   Tenorio-Salazar, Jared
RA   Garcia-Carranca, Alejandro Manuel
RA   Cerbon-Cervantes, Marco Antonio
RA   Alcantara-Quintana, Luz Eugenia
RT   "Establishment, authenticity, and characterization of cervical cancer
RT   cell lines.";
RL   Mol. Cell. Oncol. 9:2078628.1-2078628.10(2022).
//